Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Mol Carcinog. 2020 Jun 20;59(9):1052–1063. doi: 10.1002/mc.23236

FIGURE 4.

FIGURE 4

Low PRDM1 expression in humans is correlated with worse patient outcomes and metastatic melanoma. A, Overall survival of patients with metastatic melanoma compared to PRDM1 expression obtained from The Cancer Genome Atlas (TCGA). Statistical analysis was performed with a log-rank test. B, PRDM1 expression in normal skin, primary melanoma tumors, and metastatic melanoma tumors obtained from the Riker melanoma dataset. Statistical analysis was performed using a one-way ANOVA. Error bars represent mean ± SD. *P < .05, **P < .01, ***P < .001. ANOVA, analysis of variance; SD, standard deviation